# A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan

> **NCT05882279** · — · COMPLETED · sponsor: **Takeda** · enrollment: 330 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05882279
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2023-06-09
- **Final completion:** 2023-06-09
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05882279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05882279, "A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05882279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*